Malvika Kaul

1.9k total citations
36 papers, 1.6k citations indexed

About

Malvika Kaul is a scholar working on Molecular Biology, Genetics and Molecular Medicine. According to data from OpenAlex, Malvika Kaul has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Genetics and 12 papers in Molecular Medicine. Recurrent topics in Malvika Kaul's work include Antibiotic Resistance in Bacteria (12 papers), Bacterial Genetics and Biotechnology (11 papers) and RNA and protein synthesis mechanisms (10 papers). Malvika Kaul is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Bacterial Genetics and Biotechnology (11 papers) and RNA and protein synthesis mechanisms (10 papers). Malvika Kaul collaborates with scholars based in United States, Taiwan and Japan. Malvika Kaul's co-authors include Daniel S. Pilch, Christopher M. Barbieri, Edmond J. LaVoie, Ajit K. Parhi, John E. Kerrigan, Lilly Mark, Yacov Ron, Cody Kelley, Joseph P. Dougherty and Hong Yu and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Malvika Kaul

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malvika Kaul United States 24 1.1k 428 317 309 230 36 1.6k
Martin Empting Germany 29 1.6k 1.5× 188 0.4× 329 1.0× 435 1.4× 135 0.6× 78 2.2k
Dev P. Arya United States 34 2.5k 2.4× 134 0.3× 144 0.5× 537 1.7× 220 1.0× 96 3.0k
Timothy I. Meier United States 17 644 0.6× 238 0.6× 214 0.7× 64 0.2× 100 0.4× 19 1.0k
Mark R. Sanderson United Kingdom 29 2.3k 2.1× 397 0.9× 257 0.8× 334 1.1× 231 1.0× 55 2.8k
Yuk‐Ching Tse‐Dinh United States 30 1.7k 1.6× 224 0.5× 410 1.3× 282 0.9× 159 0.7× 97 2.1k
M. Sloan Siegrist United States 20 1.0k 1.0× 385 0.9× 225 0.7× 361 1.2× 351 1.5× 42 1.9k
Adam W. Barb United States 25 1.7k 1.6× 178 0.4× 219 0.7× 297 1.0× 60 0.3× 75 2.3k
Christopher M. Barbieri United States 21 1.2k 1.1× 325 0.8× 84 0.3× 86 0.3× 141 0.6× 33 1.4k
Alexandre Wohlkönig Belgium 18 1.2k 1.1× 112 0.3× 136 0.4× 124 0.4× 100 0.4× 44 1.7k
Dominik Rejman Czechia 20 857 0.8× 309 0.7× 90 0.3× 238 0.8× 160 0.7× 67 1.2k

Countries citing papers authored by Malvika Kaul

Since Specialization
Citations

This map shows the geographic impact of Malvika Kaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malvika Kaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malvika Kaul more than expected).

Fields of papers citing papers by Malvika Kaul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malvika Kaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malvika Kaul. The network helps show where Malvika Kaul may publish in the future.

Co-authorship network of co-authors of Malvika Kaul

This figure shows the co-authorship network connecting the top 25 collaborators of Malvika Kaul. A scholar is included among the top collaborators of Malvika Kaul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malvika Kaul. Malvika Kaul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaul, Malvika, et al.. (2022). Combination with a FtsZ inhibitor potentiates the in vivo efficacy of oxacillin against methicillin-resistant Staphylococcus aureus. Medicinal Chemistry Research. 31(10). 1705–1715. 7 indexed citations
2.
Parhi, Ajit K., et al.. (2019). Advances in the structural studies of antibiotic potentiators against Escherichia coli. Bioorganic & Medicinal Chemistry. 27(15). 3254–3278. 9 indexed citations
3.
Wang, Jehng-Kang, Sean D. Moore, Yee Hui Yeo, et al.. (2014). Matriptase Autoactivation Is Tightly Regulated by the Cellular Chemical Environments. PLoS ONE. 9(4). e93899–e93899. 24 indexed citations
4.
Kaul, Malvika, et al.. (2014). TXA497 as a topical antibacterial agent: Comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin. International Journal of Pharmaceutics. 476(1-2). 199–204. 14 indexed citations
5.
Kaul, Malvika, et al.. (2013). Pharmacokinetics and in vivo antistaphylococcal efficacy of TXY541, a 1-methylpiperidine-4-carboxamide prodrug of PC190723. Biochemical Pharmacology. 86(12). 1699–1707. 44 indexed citations
6.
Parhi, Ajit K., Yong‐Zheng Zhang, Kurt W. Saionz, et al.. (2013). Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines. Bioorganic & Medicinal Chemistry Letters. 23(17). 4968–4974. 145 indexed citations
7.
Parhi, Ajit K., et al.. (2013). Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 23(7). 2001–2006. 18 indexed citations
8.
Kaul, Malvika, Ajit K. Parhi, Edmond J. LaVoie, et al.. (2013). Enterococcal and streptococcal resistance to PC190723 and related compounds: Molecular insights from a FtsZ mutational analysis. Biochimie. 95(10). 1880–1887. 20 indexed citations
9.
Chen, Ya‐Wen, Jehng-Kang Wang, Han Sheng Chiu, et al.. (2013). Matriptase Regulates Proliferation and Early, but Not Terminal, Differentiation of Human Keratinocytes. Journal of Investigative Dermatology. 134(2). 405–414. 28 indexed citations
10.
Parhi, Ajit K., Songfeng Lu, Cody Kelley, et al.. (2012). Antibacterial activity of substituted dibenzo[a,g]quinolizin-7-ium derivatives. Bioorganic & Medicinal Chemistry Letters. 22(22). 6962–6966. 32 indexed citations
11.
Kelley, Cody, et al.. (2012). 3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents. Bioorganic & Medicinal Chemistry. 20(24). 7012–7029. 55 indexed citations
12.
Kelley, Cody, Songfeng Lu, Ajit K. Parhi, et al.. (2012). Antimicrobial activity of various 4- and 5-substituted 1-phenylnaphthalenes. European Journal of Medicinal Chemistry. 60. 395–409. 21 indexed citations
13.
Parhi, Ajit K., Cody Kelley, Malvika Kaul, Daniel S. Pilch, & Edmond J. LaVoie. (2012). Antibacterial activity of substituted 5-methylbenzo[c]phenanthridinium derivatives. Bioorganic & Medicinal Chemistry Letters. 22(23). 7080–7083. 38 indexed citations
14.
Kaul, Malvika, et al.. (2007). Molecular Determinants of Antibiotic Recognition and Resistance by Aminoglycoside Phosphotransferase (3′)-IIIa: A Calorimetric and Mutational Analysis. Journal of Molecular Biology. 369(1). 142–156. 13 indexed citations
15.
Barbieri, Christopher M., Malvika Kaul, & Daniel S. Pilch. (2007). Use of 2-aminopurine as a fluorescent tool for characterizing antibiotic recognition of the bacterial rRNA A-site. Tetrahedron. 63(17). 3567–3574. 30 indexed citations
16.
Kaul, Malvika, Christopher M. Barbieri, & Daniel S. Pilch. (2004). Defining the Basis for the Specificity of Aminoglycoside-rRNA Recognition: A Comparative Study of Drug Binding to the A Sites of Escherichia coli and Human rRNA. Journal of Molecular Biology. 346(1). 119–134. 62 indexed citations
17.
Kaul, Malvika, Christopher M. Barbieri, John E. Kerrigan, & Daniel S. Pilch. (2003). Coupling of Drug Protonation to the Specific Binding of Aminoglycosides to the A Site of 16S rRNA: Elucidation of the Number of Drug Amino Groups Involved and their Identities. Journal of Molecular Biology. 326(5). 1373–1387. 103 indexed citations
18.
Pilch, Daniel S., Malvika Kaul, Christopher M. Barbieri, & John E. Kerrigan. (2003). Thermodynamics of aminoglycoside–rRNA recognition. Biopolymers. 70(1). 58–79. 54 indexed citations
19.
Adelson, Martin E., et al.. (2001). An Inducible Packaging Cell System for Safe, Efficient Lentiviral Vector Production in the Absence of HIV-1 Accessory Proteins. Virology. 282(1). 77–86. 53 indexed citations
20.
Kaul, Malvika, Hong Yu, Yacov Ron, & Joseph P. Dougherty. (1998). Regulated Lentiviral Packaging Cell Line Devoid of Most Viralcis-Acting Sequences. Virology. 249(1). 167–174. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Empting Breakdown of academic impact, for papers by Dev P. Arya Breakdown of academic impact, for papers by Timothy I. Meier Breakdown of academic impact, for papers by Mark R. Sanderson Breakdown of academic impact, for papers by Yuk‐Ching Tse‐Dinh Breakdown of academic impact, for papers by M. Sloan Siegrist Breakdown of academic impact, for papers by Adam W. Barb Breakdown of academic impact, for papers by Christopher M. Barbieri Breakdown of academic impact, for papers by Alexandre Wohlkönig Breakdown of academic impact, for papers by Dominik Rejman
Rankless by CCL
2026